EMR Scar Assessment Project for Endoscope (ESCAPE) trial скачать в хорошем качестве

EMR Scar Assessment Project for Endoscope (ESCAPE) trial

To cite: Kandel P, Brand EC, Pelt J the EMR SCAR Group, et al. Gut 2019;68:1633-1641. Read the full article here: http://dx.doi.org/10.1136/gutjnl-2018.... Objective: It is unclear whether endoscopic assessment of scars after colorectal endoscopic mucosal resection (EMR) has to include biopsies, even if endoscopy is negative. Vice versa, endoscopic diagnosis of recurrent adenoma may not require biopsy before endoscopic reinterventions. We prospectively analysed various endoscopic modalities in the diagnosis of recurrence following EMR. Conclusion: Our study demonstrates very high sensitivity and accuracy for all four imaging modalities, especially NBI with NF, for diagnosis of recurrent neoplasia after EMR. Our data strongly suggest that in cases of high confidence negative optical diagnosis based on NBI-NF, no biopsy is needed to confirm absence of recurrence during colorectal EMR follow-up. A high confidence positive optical diagnosis can lead to immediate resection of any suspicious area. In all cases of low confidence, biopsy is still required.